TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 17nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
3D Structure (crystal)TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 34nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 43nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 43nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 48nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 68nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 76nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 76nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 86nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 90nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 130nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 190nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetWD repeat-containing protein 48(Homo sapiens (Human))
National Center For Advancing Translational Sciences
Curated by ChEMBL
National Center For Advancing Translational Sciences
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Inhibition of human USP1/UAF1 using Ub-AMC substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 220nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 220nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataIC50: 240nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
